Meet us at MEDICA 2025! 📅 Nov. 17–20 | Hall 3 Booth D43 | Schedule a meeting

eIFU Regulation Image

EU eIFU Regulation Update Draft: What Medical Device Professionals Need to Know

Streamlining Instructions for Use: A Key Regulatory Shift

The European Commission has introduced a significant amendment to Implementing Regulation (EU) 2021/2226, impacting how medical device manufacturers provide instructions for use (IFU). This update, outlined in the latest draft Commission Implementing Regulation, aims to expand the scope of electronic Instructions for Use (eIFU) to a broader range of medical devices, reflecting a clear preference among healthcare professionals for digital access to critical information. This article summarizes the key changes and their implications for the medical device industry.

Key Changes in the Amended Regulation

The draft Commission Implementing Regulation introduces several pivotal changes to the existing framework:

  • Expanded Scope of eIFU: The most significant change is the extension of eIFU applicability to all medical devices and their accessories intended for professional users, including those under transitional provisions of Regulation (EU) 2017/745. This broadens the previous limitation to certain devices.
  • Inclusion of Devices Without Intended Medical Purpose: The amended regulation now explicitly includes devices without an intended medical purpose, as listed in Annex XVI to Regulation (EU) 2017/745, provided they are for professional use. This ensures a consistent approach across a wider spectrum of products.
  • Clarification for Lay Persons: For devices intended for professional use but also foreseeably used by lay persons (e.g., patients), manufacturers are still required to provide paper-based IFU for lay users. This maintains a crucial safety net for non-professionals.
  • Eudamed UDI Database Integration: Manufacturers will be required to provide the internet address where eIFU are accessible to Eudamed's Unique Device Identifier (UDI) database. This becomes mandatory from the date the UDI database registration applies, streamlining access to digital IFU.
  • Streamlined Requirements: Some existing requirements in Implementing Regulation (EU) 2021/2226 have been clarified or deleted to remove uncertainties and redundancies. For instance, separate requirements for information supplied by the manufacturer are removed as they are already covered by conformity assessment activities under Regulation (EU) 2017/745.

Implications for the Medical Device Industry

These amendments signify a move towards greater digitalization in the medical device sector. For manufacturers, this means a potential reduction in printing and distribution costs associated with paper IFU, alongside an increased emphasis on robust digital infrastructure for hosting and managing eIFU. The integration with the Eudamed UDI database underscores the growing importance of centralized digital information systems in EU medical device regulation. Companies will need to ensure their systems are compliant with the new requirements for providing internet addresses for eIFU.

Conclusion

The European Commission's latest draft amendment to Implementing Regulation (EU) 2021/2226 marks a significant step in modernizing the provision of Instructions for Use for medical devices. By expanding the scope of eIFU and integrating with the Eudamed UDI database, the regulation aims to enhance efficiency, reduce environmental impact, and improve accessibility of information for healthcare professionals. Medical device manufacturers should review these updates carefully to ensure timely compliance and leverage the benefits of digital transformation.

Reference

Source: 2. draft act_amendment eIFU Regulation_Committee MD_6.6.2025 (June 2025).

Latest news

Implications of the Update to the Borderline & Classification Manual under MDR and IVDR

Implications of the Update to the Borderline & Classification Manual under MDR and IVDR

On 12 September 2025, the European Commission published Version 4 of the Manual on Borderline and Classification under Regulations (EU) 2017/745 and 2017/746, developed by the Borderline and Classification Working Group (BCWG).

Regulatory Affairs Bulletin: Intended Purpose vs Intended Use under MDR & IVDR

Regulatory Affairs Bulletin: Intended Purpose vs Intended Use under MDR & IVDR

European regulations EU 2017/745 (MDR) and EU 2017/746 (IVDR) require precise definitions in technical documentation, and the distinction (or overlap) between intended purpose and intended use remains a topic of operational significance.

MedNet EC-REP GmbH at MEDICA 2025 – Visit Us in Hall 3, Booth D43

MedNet EC-REP GmbH at MEDICA 2025 – Visit Us in Hall 3, Booth D43

MedNet EC-REP GmbH is pleased to announce that we will once again be exhibiting at MEDICA 2025 in Düsseldorf, the world’s leading trade fair for the medical technology industry.

Understanding the Interplay: MDR, IVDR, and the AI Act – Key Insights from MDCG 2025-6

Understanding the Interplay: MDR, IVDR, and the AI Act – Key Insights from MDCG 2025-6

Recently, the MDCG, in conjunction with the Joint Artificial Intelligence Board (AIB), released the MDCG 2025-6 FAQ document, offering essential clarifications on the interplay between the MDR, the IVDR, and the Artificial Intelligence Act (AIA).

Navigating IVDR and MDR Performance Studies: Key Insights from MDCG 2025-5 Q&A

Navigating IVDR and MDR Performance Studies: Key Insights from MDCG 2025-5 Q&A

The European Medical Device Coordination Group (MDCG) has released its latest guidance, MDCG 2025-5, a comprehensive Questions & Answers document addressing performance studies for in vitro diagnostic medical devices (IVDs) under Regulation (EU) 2017/746 (IVDR).

MDCG 2019-11 Rev.1: Important Changes for Medical Device Software Developers

MDCG 2019-11 Rev.1: Important Changes for Medical Device Software Developers

In the dynamic world of medical device regulation, staying abreast of the latest guidance is paramount for manufacturers. The Medical Device Coordination Group (MDCG) has recently released a significant update to its MDCG 2019-11 guidance document, now designated as MDCG 2019-11 Rev.1.

MDCG 2025-4: Key Guidance for Medical Device Software on Online Platforms

MDCG 2025-4: Key Guidance for Medical Device Software on Online Platforms

The European Commission's Medical Device Coordination Group (MDCG) has released the MDCG 2025-4 guidance document, titled "Guidance on the safe making available of medical device software (MDSW) apps on online platforms."